Long Term Debt Summary of Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited's latest annual long term debt in 2023 was 26.56 Million INR , down -29.5% from previous year.
Shukra Pharmaceuticals Limited's latest quarterly long term debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
Shukra Pharmaceuticals Limited reported annual long term debt of 37.68 Million INR in 2022, up 20.52% from previous year.
Shukra Pharmaceuticals Limited reported annual long term debt of 31.26 Million INR in 2021, down -68.0% from previous year.
Shukra Pharmaceuticals Limited reported quarterly long term debt of 18.88 Million INR for 2023 Q2, down 0.0% from previous quarter.
Shukra Pharmaceuticals Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Shukra Pharmaceuticals Limited (2023 - 2012)

Historical Annual Long Term Debt of Shukra Pharmaceuticals Limited (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	26.56 Million INR	-29.5%
2022	37.68 Million INR	20.52%
2021	31.26 Million INR	-68.0%
2020	97.7 Million INR	21.35%
2019	80.51 Million INR	32.94%
2018	60.56 Million INR	69.03%
2017	35.83 Million INR	9853.88%
2016	360 Thousand INR	0.0%
2015	360 Thousand INR	-96.99%
2014	11.96 Million INR	284.57%
2013	3.11 Million INR	-96.93%
2012	101.17 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- INR	-100.0%
2023 Q2	18.88 Million INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 FY	26.56 Million INR	-29.5%
2023 Q4	26.56 Million INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q4	37.68 Million INR	0.0%
2022 FY	37.68 Million INR	20.52%
2022 Q2	13.95 Million INR	0.0%
2021 Q4	31.26 Million INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 FY	31.26 Million INR	-68.0%
2021 Q2	104.69 Million INR	0.0%
2020 Q4	97.7 Million INR	0.0%
2020 FY	97.7 Million INR	21.35%
2020 Q1	- INR	-100.0%
2020 Q2	96.1 Million INR	0.0%
2020 Q3	- INR	-100.0%
2019 FY	80.51 Million INR	32.94%
2019 Q1	- INR	-100.0%
2019 Q4	80.51 Million INR	0.0%
2018 Q4	60.56 Million INR	0.0%
2018 Q2	49.56 Million INR	0.0%
2018 Q1	- INR	-100.0%
2018 FY	60.56 Million INR	69.03%
2017 FY	35.83 Million INR	9853.88%
2017 Q3	- INR	-100.0%
2017 Q2	20.98 Million INR	0.0%
2017 Q1	- INR	-100.0%
2017 Q4	35.83 Million INR	0.0%
2016 Q1	- INR	-100.0%
2016 FY	360 Thousand INR	0.0%
2016 Q4	360 Thousand INR	0.0%
2016 Q3	- INR	0.0%
2016 Q2	- INR	0.0%
2015 Q2	- INR	-100.0%
2015 FY	360 Thousand INR	-96.99%
2015 Q4	360 Thousand INR	0.0%
2015 Q3	360 Thousand INR	0.0%
2015 Q1	2.15 Million INR	-82.02%
2014 Q4	11.96 Million INR	285.81%
2014 Q1	2.61 Million INR	-16.08%
2014 FY	11.96 Million INR	284.57%
2014 Q3	3.1 Million INR	-72.07%
2014 Q2	11.1 Million INR	325.29%
2013 Q3	101.63 Million INR	0.09%
2013 Q4	3.11 Million INR	-96.94%
2013 FY	3.11 Million INR	-96.93%
2013 Q2	101.53 Million INR	0.12%
2013 Q1	101.41 Million INR	0.24%
2012 Q4	101.17 Million INR	0.0%
2012 Q3	- INR	-100.0%
2012 Q2	105.75 Million INR	0.0%
2012 FY	101.17 Million INR	0.0%
2011 Q4	104.93 Million INR	0.0%

Peer Long Term Debt Comparison of Shukra Pharmaceuticals Limited

Name	Long Term Debt	Long Term Debt Difference
DECIPHER LABS LIMITED	- INR	-Infinity%
Gujarat Themis Biosyn Limited	12.24 Million INR	-116.927%
Ishita Drugs and Industries Limited	- INR	-Infinity%
MedPlus Health Services Limited	8.68 Billion INR	99.694%
ANG Lifesciences India Limited	139.49 Million INR	80.954%
Add-Shop E-Retail Limited	5.73 Million INR	-363.486%
Bacil Pharma Limited	- INR	-Infinity%
BDH Industries Limited	- INR	-Infinity%
Beryl Drugs Limited	24.03 Million INR	-10.521%
Cian Healthcare Limited	274.96 Million INR	90.338%
Chemo Pharma Laboratories Limited	- INR	-Infinity%
Concord Drugs Limited	6.45 Million INR	-311.636%
Deccan Health Care Limited	16.77 Million INR	-58.382%
Gujarat Terce Laboratories Limited	9.27 Million INR	-186.468%
Hindustan Bio Sciences Limited	25.56 Million INR	-3.926%
Jenburkt Pharmaceuticals Limited	- INR	-Infinity%
KIMIA BIOSCIENCES LIMITED	214.09 Million INR	87.591%
Kwality Pharmaceuticals Limited	195.6 Million INR	86.418%
Makers Laboratories Limited	90.84 Million INR	70.757%
Medi-Caps Limited	- INR	-Infinity%
Panchsheel Organics Limited	2.72 Million INR	-876.728%
Parmax Pharma Limited	44.79 Million INR	40.687%
Parnax Lab Limited	210.53 Million INR	87.381%
Patidar Buildcon Limited	25.32 Million INR	-4.913%
Phaarmasia Limited	114 Thousand INR	-23204.386%
Vikram Thermo (India) Limited	47.12 Million INR	43.626%
Sanjivani Paranteral Limited.	9.69 Million INR	-174.141%
SHAMROCK INDUSTRIAL CO.LTD.	- INR	-Infinity%
Smruthi Organics Limited	55.61 Million INR	52.232%
Source Natural Foods and Herbal Supplements Limited	- INR	-Infinity%
SUDARSHAN PHARMA INDUSTRIES LI	104.91 Million INR	74.677%
Trident Lifeline Limited	127.99 Million INR	79.244%
Transchem Limited	- INR	-Infinity%
Trinity League India Limited	- INR	-Infinity%
Tyche Industries Limited	- INR	-Infinity%
Vista Pharmaceuticals Limited	29.32 Million INR	9.417%
Vivanza Biosciences Limited	26.82 Million INR	0.943%
PRAVEG LIMITED	595.61 Million INR	95.54%
Sastasundar Ventures Limited	28.65 Million INR	7.28%
Sunil Healthcare Limited	207.29 Million INR	87.184%
Syschem (India) Limited	4.5 Million INR	-490.378%
Zenith Healthcare Limited	- INR	-Infinity%
Zenlabs Ethica Limited	15.93 Million INR	-66.732%
Mercury Laboratories Limited	28.64 Million INR	7.248%
SHELTER PHARMA LIMITED	5.73 Million INR	-363.486%
Vasundhara Rasayans Limited	7.89 Million INR	-236.547%
Bharat Immunologicals & Biologicals Corporation Limited	- INR	-Infinity%
Roopa Industries Limited	52.79 Million INR	49.674%
PANJON LTD.	1.41 Million INR	-1781.516%
Pharmaids Pharmaceuticals Limited	35.85 Million INR	25.902%
TIAAN CONSUMER LIMITED	- INR	-Infinity%
Anuh Pharma Limited	3.88 Million INR	-584.187%
Crestchem Limited	- INR	-Infinity%
Emmessar Biotech & Nutrition Limited	- INR	-Infinity%
Sandu Pharmaceuticals Limited	603 Thousand INR	-4305.804%
Fredun Pharmaceuticals Limited	51.51 Million INR	48.425%
Trimurthi Limited	- INR	-Infinity%
Norris Medicines Limited	185.91 Million INR	85.71%
Veerhealth Care Limited	- INR	-Infinity%
Lactose (India) Limited	241.88 Million INR	89.017%
OXYGENTA PHARMACEUTICAL LIMITE	490.01 Million INR	94.578%
Ambalal Sarabhai Enterprises Limited	90.58 Million INR	70.673%
Gennex Laboratories Limited	132.16 Million INR	79.898%
Denis Chem Lab Limited	4.51 Million INR	-488.156%
Colinz Laboratories Limited	- INR	-Infinity%
Godavari Drugs Limited	111.67 Million INR	76.21%
Zenotech Laboratories Limited	- INR	-Infinity%
Shree Ganesh Remedies Limited	291.18 Million INR	90.876%
Bharat Parenterals Limited	731.62 Million INR	96.369%
Coral Laboratories Limited	- INR	-Infinity%
Evoq Remedies Limited	- INR	-Infinity%
Kerala Ayurveda Limited	594.16 Million INR	95.529%
KOBO BIOTECH LIMITED	317.14 Million INR	91.623%
Natural Capsules Limited	679.33 Million INR	96.089%
Auro Laboratories Limited	183.78 Million INR	85.544%

Global Stocks Search

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)

Long Term Debt Summary of Shukra Pharmaceuticals Limited

Annual Long Term Debt Chart of Shukra Pharmaceuticals Limited (2023 - 2012)

Historical Annual Long Term Debt of Shukra Pharmaceuticals Limited (2023 - 2012)

Peer Long Term Debt Comparison of Shukra Pharmaceuticals Limited